Impact of HER2 expression on outcome in gastric cancer patients with liver metastasis

被引：0
作者：
H. Jiang
Q. Li
S. Yu
Y. Yu
Y. Wang
W. Li
Y. Cui
T. Liu
机构：
[1] Fudan University,Department of Medical Oncology, Zhongshan Hospital
来源：
Clinical and Translational Oncology | 2017年 / 19卷
关键词：
Stomach neoplasm; HER2; Trastuzumab; Liver metastasis; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：197 / 203
页数：6
相关论文
共 50 条
  • [1] Impact of HER2 expression on outcome in gastric cancer patients with liver metastasis
    Jiang, H.
    Li, Q.
    Yu, S.
    Yu, Y.
    Wang, Y.
    Li, W.
    Cui, Y.
    Liu, T.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (02) : 197 - 203
  • [2] Prognosis of HER2 over-expressing gastric cancer patients with liver metastasis
    Hai-Zhen Dang
    World Journal of Gastroenterology, 2012, (19) : 2402 - 2407
  • [3] Prognosis of HER2 over-expressing gastric cancer patients with liver metastasis
    Dang, Hai-Zhen
    Yu, Yang
    Jiao, Shun-Chang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (19) : 2402 - 2407
  • [4] HER2/neu over-expression predicts poor outcome in early gastric cancer without lymph node metastasis
    Yan, Yongjia
    Lu, Li
    Liu, Chunna
    Li, Weidong
    Liu, Tong
    Fu, Weihua
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2015, 39 (01) : 121 - 126
  • [5] Preferential HER2 expression in liver metastases and EGFR expression in peritoneal metastases in patients with advanced gastric cancer
    Saito, Takuya
    Nakanishi, Hayao
    Mochizuki, Yoshinari
    Ito, Seiji
    Ito, Yuichi
    Misawa, Kazunari
    Yatabe, Yasushi
    Yamamichi, Keigo
    Kondo, Eisaku
    GASTRIC CANCER, 2015, 18 (04) : 711 - 719
  • [6] HER2 expression in primary gastric cancers and paired synchronous lymph node and liver metastases. A possible road to target HER2 with radionuclides
    Wei, Qichun
    Xu, Jing
    Shen, Li
    Fu, Xianhua
    Zhang, Bicheng
    Zhou, Xiaofeng
    Carlsson, Jorgen
    TUMOR BIOLOGY, 2014, 35 (07) : 6319 - 6326
  • [7] Prognostic Significance of HER2 Expression for Gastric Cancer With Clinically Para-aortic Lymph Node Metastasis
    Arigami, Takaaki
    Matsushita, Daisuke
    Okubo, Keishi
    Sasaki, Ken
    Tsuruda, Yusuke
    Kita, Yoshiaki
    Mori, Shinichiro
    Yanagita, Shigehiro
    Uenosono, Yoshikazu
    Kurahara, Hiroshi
    Ohtsuka, Takao
    ANTICANCER RESEARCH, 2021, 41 (06) : 3099 - 3107
  • [8] The relationship between brain metastasis and HER2 expression status in gastric cancer
    Lai, Ming-Yu
    Guan, Wen-Long
    Yang, Jing
    Sun, Yu-Ting
    Lu, Shi-Xun
    Yang, Li-Qiong
    Yang, Da-Jun
    Qiu, Miao-Zhen
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (03) : 765 - 773
  • [9] The Impact of Pembrolizumab as a Salvage Therapy Based on HER2 Expression in Advanced Gastric Cancer
    Lim, Sung Hee
    Kim, Min Jung
    Lee, Jeeyun
    Lim, Ho Yeong
    Kang, Won Ki
    Kim, Seung Tae
    CANCERS, 2024, 16 (17)
  • [10] Outcome Evaluation of HER2 Breast Cancer Patients with Limited Brain Metastasis
    Pessina, Federico
    Navarria, Pierina
    Cozzi, Luca
    Franceschini, Davide
    Tomatis, Stefano
    Clerici, Elena
    Ascolese, Anna Maria
    De Rose, Fiorenza
    Bello, Lorenzo
    Masci, Giovanna
    Santoro, Armando
    Scorsetti, Marta
    ANTICANCER RESEARCH, 2017, 37 (12) : 7057 - 7062
12345